Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
European Journal of Haematology|September 30, 2018
Increased survival due to lower toxicity for high-risk T-cell acute lymphoblastic leukemia patients in two consecutive pediatric-inspired PETHEMA trialsPere Barba, Mireia Morgades, Pau Montesinos, et al.Blood Neoplasia|August 1, 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemiaMartin Hutchings, Koorosh Korfi, Pau Montesinos, et al.Mediterranean Journal of Hematology and Infectious Diseases|March 13, 2019
Differences in ex-vivo Chemosensitivity to Anthracyclines in First Line Acute Myeloid LeukemiaJuan Eduardo Megías-Vericat, David Martínez-Cuadrón, Joaquín Martínez López, et al.Leukemia & Lymphoma|November 23, 2017
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Pau Montesinos, et al.Hemasphere|March 4, 2024
Integrative single-cell expression and functional studies unravels a sensitization to cytarabine-based chemotherapy through HIF pathway inhibition in AML leukemia stem cellsTalia Velasco-Hernandez, Juan L Trincado, Meritxell Vinyoles, et al.Blood Advances|December 15, 2021
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocolAlex Bataller, Ana Garrido, Francesca Guijarro, et al.Cancers|May 14, 2022
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA RegistryJorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente, et al.Cancers|April 12, 2022
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry ExperienceJorge Labrador, Miriam Saiz-Rodríguez, Dunia de Miguel, et al.Cancers|December 17, 2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA GroupsSusana Vives, David Quintela, Mireia Morgades, et al.British Journal of Haematology|March 28, 2019
The poor prognosis of low hypodiploidy in adults with B-cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patientsJordi Ribera, Isabel Granada, Mireia Morgades, et al.Pageof 9